|
Name |
2-hydroxy-8-methoxy-6-methyl-9-oxo-xanthene-1-carboxylic Acid
|
| Molecular Formula | C16H12O6 | |
| IUPAC Name* |
2-hydroxy-8-methoxy-6-methyl-9-oxoxanthene-1-carboxylic acid
|
|
| SMILES |
CC1=CC2=C(C(=C1)OC)C(=O)C3=C(O2)C=CC(=C3C(=O)O)O
|
|
| InChI |
InChI=1S/C16H12O6/c1-7-5-10(21-2)13-11(6-7)22-9-4-3-8(17)12(16(19)20)14(9)15(13)18/h3-6,17H,1-2H3,(H,19,20)
|
|
| InChIKey |
BQOVQGSBHRLTFG-UHFFFAOYSA-N
|
|
| Synonyms |
CHEMBL592384; 2-hydroxy-6-methyl-8-methoxy-9-oxo-9h-xanthene-1-carboxylic acid; 2-hydroxy-8-methoxy-6-methyl-9-oxo-xanthene-1-carboxylic Acid; BDBM50339594; 2-hydroxy-8-methoxy-6-methyl-9-oxo-9H-xanthene-1-carboxylic acid
|
|
| CAS | NA | |
| PubChem CID | 11438030 | |
| ChEMBL ID | CHEMBL592384 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 300.26 | ALogp: | 3.0 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 22 | QED Weighted: | 0.703 |
| Caco-2 Permeability: | -4.885 | MDCK Permeability: | 0.00000709 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.778 |
| Human Intestinal Absorption (HIA): | 0.041 | 20% Bioavailability (F20%): | 0.009 |
| 30% Bioavailability (F30%): | 0.658 |
| Blood-Brain-Barrier Penetration (BBB): | 0.045 | Plasma Protein Binding (PPB): | 86.05% |
| Volume Distribution (VD): | 0.726 | Fu: | 11.00% |
| CYP1A2-inhibitor: | 0.343 | CYP1A2-substrate: | 0.931 |
| CYP2C19-inhibitor: | 0.069 | CYP2C19-substrate: | 0.057 |
| CYP2C9-inhibitor: | 0.512 | CYP2C9-substrate: | 0.265 |
| CYP2D6-inhibitor: | 0.457 | CYP2D6-substrate: | 0.15 |
| CYP3A4-inhibitor: | 0.072 | CYP3A4-substrate: | 0.057 |
| Clearance (CL): | 1.308 | Half-life (T1/2): | 0.831 |
| hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.112 |
| Drug-inuced Liver Injury (DILI): | 0.988 | AMES Toxicity: | 0.221 |
| Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.105 |
| Skin Sensitization: | 0.522 | Carcinogencity: | 0.11 |
| Eye Corrosion: | 0.018 | Eye Irritation: | 0.945 |
| Respiratory Toxicity: | 0.497 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002135 | ![]() |
0.783 | D06GCK | ![]() |
0.372 | ||
| ENC001749 | ![]() |
0.714 | D0G5UB | ![]() |
0.348 | ||
| ENC002404 | ![]() |
0.658 | D0K8KX | ![]() |
0.333 | ||
| ENC004289 | ![]() |
0.600 | D04AIT | ![]() |
0.326 | ||
| ENC005347 | ![]() |
0.597 | D07MGA | ![]() |
0.315 | ||
| ENC002668 | ![]() |
0.577 | D0QD1G | ![]() |
0.309 | ||
| ENC002106 | ![]() |
0.573 | D06NSS | ![]() |
0.292 | ||
| ENC005168 | ![]() |
0.541 | D0G7IY | ![]() |
0.292 | ||
| ENC002462 | ![]() |
0.538 | D08LFZ | ![]() |
0.282 | ||
| ENC002523 | ![]() |
0.533 | D0Y7PG | ![]() |
0.281 | ||